The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
v Integrins in Angiogenesis and Cancer
Open accessAbstract
During angiogenesis, αv integrins are overexpressed on the endothelial cell surface to facilitate the growth and survival of newly forming vessels. Accordingly, blocking αv integrin function by disrupting ligand binding can produce an antiangiogenic effect. Although the integrin ectodomain regulates ligand binding specificity, the short cytoplasmic tail facilitates intracellular signaling pathways through the recruitment and activation of specific kinases and signaling intermediates. This in turn controls endothelial cell adhesion, morphology, migration, invasion, proliferation, and survival. These same integrin-mediated signaling pathways are exploited in cancer to promote the invasiveness and survival of tumor cells and to manipulate the host microenvironment to provide ample blood vessel and stromal resources to support tumor growth and metastatic spread. Because expression of αv integrins on distinct cell types contributes to cancer growth, αv integrin antagonists have the potential to disrupt multiple aspects of disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Concomitant suppression of three target genes can explain the impact of a microRNA on metastasisPreprint
Valastyan, S., Benaich, N., Chang, A., Reinhardt, F., & Weinberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1832709 · Cited by 105
RetractedIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Self-citationPierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Self-citationIntegrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Self-citationHumphries, J. D., Byron, A., & Humphries, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03098 · Cited by 1,708
Structural Basis of Integrin Regulation and Signaling
Luo, B.-H., Carman, C. V., & Springer, T. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141618 · Cited by 1,660
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Self-citationMicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Cell · doi:10.1016/0092-8674(85)90322-8 · Cited by 1,101
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Self-citationAntiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Self-citationHodivala-Dilke, K. M., McHugh, K. P., Tsakiris, D. A., Rayburn, H., Crowley, D., Ullman-Culleré, M., Ross, F. P., Coller, B. S., Teitelbaum, S., & Hynes, R. O. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5487 · Cited by 740
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.5985 · Cited by 681
CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration
Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., & Cheresh, D. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.961 · Cited by 659
Self-citationEnhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
Bone Marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature
Ziegelhoeffer, T., Fernandez, B., Kostin, S., Heil, M., Voswinckel, R., Helisch, A., & Schaper, W. (2004) · Circulation Research · doi:10.1161/01.res.0000110419.50982.1c · Cited by 605
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function
Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., et al. (2003) · Nature · doi:10.1038/nature01784 · Cited by 576
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Aumailley, M., Gurrath, M., Müller, G., Calvete, J., Timpl, R., & Kessler, H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81101-d · Cited by 551
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5766 · Cited by 511
Reynolds, A. R., Hart, I. R., Watson, A. R., Welti, J. C., Silva, R. G., Robinson, S. D., Da Violante, G., Gourlaouen, M., Salih, M., Jones, M. C., et al. (2009) · Nature Medicine · doi:10.1038/nm.1941 · Cited by 490
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Integrins: masters and slaves of endocytic transport
Caswell, P. T., Vadrevu, S., & Norman, J. C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2799 · Cited by 460
Interaction of endostatin with integrins implicated in angiogenesis
Rehn, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031564998 · Cited by 460
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Self-citationInvolvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.
Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S., & Cheresh, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9764 · Cited by 452
Self-citationIntegrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.
Montgomery, A. M., Reisfeld, R. A., & Cheresh, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8856 · Cited by 448
Self-citationGladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationMicroRNAs As Novel Regulators of Angiogenesis
Suárez, Y., & Sessa, W. C. (2009) · Circulation Research · doi:10.1161/circresaha.108.191270 · Cited by 416
Caswell, P. T., Chan, M., Lindsay, A. J., McCaffrey, M. W., Boettiger, D., & Norman, J. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804140 · Cited by 388
Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells
Ezratty, E. J., Bertaux, C., Marcantonio, E. E., & Gundersen, G. G. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904054 · Cited by 376
Positional Control of Cell Fate Through Joint Integrin/Receptor Protein Kinase Signaling
Giancotti, F. G., & Tarone, G. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.031103.133334 · Cited by 374
Signalling via integrins: Implications for cell survival and anticancer strategies
Hehlgans, S., Haase, M., & Cordes, N. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.09.001 · Cited by 373
MicroRNAs and the hallmarks of cancer
Dalmay, T., & Edwards, D. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209911 · Cited by 366
αvβ3 and αvβ5 Integrin Expression in Glioma Periphery
Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., Nikas, D. C., Strasser, J. F., Villani, R., Cheresh, D. A., & Black, P. M. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00022 · Cited by 341
Self-citationRole of Raf in Vascular Protection from Distinct Apoptotic Stimuli
Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., & Cheresh, D. A. (2003) · Science · doi:10.1126/science.1082015 · Cited by 336
Self-citationA functional study of miR-124 in the developing neural tube
Cao, X., Pfaff, S. L., & Gage, F. H. (2007) · Genes & Development · doi:10.1101/gad.1519207 · Cited by 336
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3756 · Cited by 310
Self-citationDrake, C. J., Cheresh, D. A., & Little, C. D. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.7.2655 · Cited by 307
Self-citationMechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis
Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., & Byzova, T. V. (2007) · Circulation Research · doi:10.1161/circresaha.107.155655 · Cited by 298
An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
Desgrosellier, J. S., Barnes, L. A., Shields, D. J., Huang, M., Lau, S. K., Prévost, N., Tarin, D., Shattil, S. J., & Cheresh, D. A. (2009) · Nature Medicine · doi:10.1038/nm.2009 · Cited by 293
Self-citationMeyer, A., Auernheimer, J., Modlinger, A., & Kessler, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947740 · Cited by 291
Neuropilin-1/GIPC1 Signaling Regulates α5β1 Integrin Traffic and Function in Endothelial Cells
Valdembri, D., Caswell, P. T., Anderson, K. I., Schwarz, J. P., König, I., Astanina, E., Caccavari, F., Norman, J. C., Humphries, M. J., Bussolino, F., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000025 · Cited by 271
Klemke, R. L., Yebra, M., Bayna, E. M., & Cheresh, D. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.3.859 · Cited by 270
Self-citationβ8 integrins are required for vascular morphogenesis in mouse embryos
Zhu, J., Motejlek, K., Wang, D., Zang, K., Schmidt, A., & Reichardt, L. F. (2002) · Development · doi:10.1242/dev.129.12.2891 · Cited by 267
Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
Hood, J. D., Frausto, R., Kiosses, W. B., Schwartz, M. A., & Cheresh, D. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304105 · Cited by 262
Self-citationIntegrins: The Keys to Unlocking Angiogenesis
Silva, R., D'Amico, G., Hodivala-Dilke, K. M., & Reynolds, L. E. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.172015 · Cited by 255
Targeting microRNA expression to regulate angiogenesis
Kuehbacher, A., Urbich, C., & Dimmeler, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.014 · Cited by 248
MacDonald, T. J., Taga, T., Shimada, H., Tabrizi, P., Zlokovic, B. V., Cheresh, D. A., & Laug, W. E. (2001) · Neurosurgery · doi:10.1097/00006123-200101000-00026 · Cited by 240
Self-citationMcCarty, J. H., Lacy-Hulbert, A., Charest, A., Bronson, R. T., Crowley, D., Housman, D., Savill, J., Roes, J., & Hynes, R. O. (2005) · Development · doi:10.1242/dev.01551 · Cited by 235
Hutchings, H., Ortega, N., & Plouët, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0691fje · Cited by 235
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
Acevedo, L. M., Barillas, S., Weis, S. M., Göthert, J. R., & Cheresh, D. A. (2008) · Blood · doi:10.1182/blood-2007-08-110205 · Cited by 232
Self-citationDefining the Role of Integrin αvβ6 in Cancer
Bandyopadhyay, A., & Raghavan, S. (2009) · Current Drug Targets · doi:10.2174/138945009788680374 · Cited by 228
Suzuki, S., Argraves, W. S., Pytela, R., Arai, H., Krusius, T., Pierschbacher, M. D., & Ruoslahti, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8614 · Cited by 226
Maione, F., Molla, F., Meda, C., Latini, R., Zentilin, L., Giacca, M., Seano, G., Serini, G., Bussolino, F., & Giraudo, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36308 · Cited by 219
Induction of the Angiogenic Phenotype by Hox D3
Boudreau, N., Andrews, C., Srebrow, A., Ravanpay, A., & Cheresh, D. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.257 · Cited by 208
Self-citationProstate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling
McCabe, N. P., De, S., Vasanji, A., Brainard, J., & Byzova, T. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210429 · Cited by 207
Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
Müller, D. W., & Bosserhoff, A.-K. (2008) · Oncogene · doi:10.1038/onc.2008.282 · Cited by 206
Integrin signaling is critical for pathological angiogenesis
Mahabeleshwar, G. H., Feng, W., Phillips, D. R., & Byzova, T. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060807 · Cited by 206
Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A., Lipson, K. E., Saffrich, R., Gröne, H.-J., Hallahan, D. E., Reisfeld, R. A., Debus, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1223 · Cited by 205
The Extracellular Matrix of Gliomas: Modulation of Cell Function
Gladson, C. L. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199910000-00001 · Cited by 199
Specific Interaction of Angiostatin with Integrin αvβ3 in Endothelial Cells
Tarui, T., Miles, L. A., & Takada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101815200 · Cited by 197
Transient functional expression of alphaVbeta 3 on vascular cells during wound repair.
Clark, R. A. F., Tonnesen, M. G., Gailit, J. O., & Cheresh, D. A. (1996) · Europe PMC (PubMed Central) · Cited by 196
Self-citationEndogenous inhibitors of angiogenesis
Ribatti, D. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.019 · Cited by 191
Hersey, P., Sosman, J., O'Day, S., Richards, J., Bedikian, A., Gonzalez, R., Sharfman, W., Weber, R., Logan, T., Buzoianu, M., et al. (2010) · Cancer · doi:10.1002/cncr.24821 · Cited by 189
Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brain
Lorger, M., Krueger, J. S., O'Neal, M., Staflin, K., & Felding-Habermann, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903035106 · Cited by 185
Cascone, I., Napione, L., Maniero, F., Serini, G., & Bussolino, F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507082 · Cited by 179
VEGF–integrin interplay controls tumor growth and vascularization
De, S., Razorenova, O., McCabe, N. P., O'Toole, T., Qin, J., & Byzova, T. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502935102 · Cited by 178
Semaphorin‐4A, an activator for T‐cell‐mediated immunity, suppresses angiogenesis via Plexin‐D1
Toyofuku, T., Yabuki, M., Kamei, J., Kamei, M., Makino, N., Kumanogoh, A., & Hori, M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601589 · Cited by 175
Nip, J., Shibata, H., Loskutoff, D. J., Cheresh, D. A., & Brodt, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116007 · Cited by 172
Self-citationBrooks, P. C., Klemke, R. L., Schon, S., Lewis, J. M., Schwartz, M. A., & Cheresh, D. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119298 · Cited by 168
Self-citationZhu, C.-Q., Popova, S. N., Brown, E. R. S., Barsyte-Lovejoy, D., Navab, R., Shih, W., Li, M., Lu, M., Jurisica, I., Penn, L. Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703040104 · Cited by 167
Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M., & Wijelath, E. S. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-8 · Cited by 161
MicroRNAs: Opening a New Vein in Angiogenesis Research
Fish, J. E., & Srivastava, D. (2009) · Science Signaling · doi:10.1126/scisignal.252pe1 · Cited by 160
Reynolds, A. R., Reynolds, L. E., Nagel, T., Lively, J. C., Robinson, S. D., Hicklin, D. J., Bodary, S. C., & Hodivala‐Dilke, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2760 · Cited by 157
Magnon, C., Galaup, A., Mullan, B., Rouffiac, V., Bidart, J., Griscelli, F., Opolon, P., & Perricaudet, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3536 · Cited by 156
Trikha, M., Zhao, Z., Nemeth, J. A., Chen, Q., Sharp, C. M., Emmell, E., Giles-Komar, J. M., & Nakada, M. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20116 · Cited by 155
Reynolds, L. E., Conti, F. J. A., Lucas, M., Grose, R. P., Robinson, S. D., Stone, M., Saunders, G., Dickson, C., Hynes, R. O., Lacy‐Hulbert, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1165 · Cited by 149
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
Dorrell, M. I., Aguilar, E., Scheppke, L., Barnett, F. H., & Friedlander, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607542104 · Cited by 147
Mullamitha, S., Ton, N. C., Parker, G. J. M., Jackson, A., Julyan, P. J., Roberts, C., Buonaccorsi, G. A., Watson, Y., Davies, K. E., Cheung, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2779 · Cited by 146
Ricono, J. M., Huang, M., Barnes, L. A., Lau, S. K. M., Weis, S. M., Schlaepfer, D. D., Hanks, S. K., & Cheresh, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3612 · Cited by 145
Self-citationHosotani, R., Kawaguchi, M., Masui, T., Koshiba, T., Ida, J., Fujimoto, K., Wada, M., Doi, R., & Imamura, M. (2002) · Pancreas · doi:10.1097/00006676-200208000-00021 · Cited by 143
Smith, J. W., Ruggeri, Z. M., Kunicki, T. J., & Cheresh, D. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38340-1 · Cited by 136
Self-citationCerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
Gladson, C. L., Wilcox, J. N., Sanders, L. C., Gillespie, G. Y., & Cheresh, D. A. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.3.947 · Cited by 136
Self-citationDanen, E. H. J., ten Berge, P. J. M., van Muijen, G. N. P., Hof‐Grootenboer, A. E. V., Bröcker, E. ‐., & Ruiter, D. J. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00517.x · Cited by 123
Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
Landen, C. N., Kim, T.-J., Lin, Y. G., Merritt, W. M., Kamat, A. A., Han, L. Y., Spannuth, W. A., Nick, A. M., Jennnings, N. B., Kinch, M. S., et al. (2008) · Neoplasia · doi:10.1593/neo.08740 · Cited by 120
Argraves, W. S., Pytela, R., Suzuki, S., Millán, J. L., Pierschbacher, M. D., & Ruoslahti, E. I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69249-x · Cited by 115
Delbaldo, C., Raymond, É., Vera, K., Hammershaimb, L., Kaucic, K., Lozahic, S., Marty, M. E., & Faivre, S. J. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9077-0 · Cited by 101
Targeting integrins in malignant glioma
Tabatabai, G., Weller, M., Nabors, B., Picard, M. A., Reardon, D. A., Mikkelsen, T., Rüegg, C., & Stupp, R. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0156-3 · Cited by 98
Chen, Q., Manning, C. D., Millar, H. J., McCabe, F. L., Ferrante, C. A., Sharp, C. M., Shahied-Arruda, L., Doshi, P. D., Nakada, M. T., & Anderson, G. M. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9132-4 · Cited by 92
Robinson, S. D., Reynolds, L. E., Kostourou, V., Reynolds, A. R., da Silva, R. G., Tavora, B., Baker, M., Marshall, J. F., & Hodivala‐Dilke, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030700 · Cited by 88
Zhang, Z., Ramirez, N. E., Yankeelov, T. E., Li, Z., Ford, L. E., Qi, Y., Pozzi, A., & Zutter, M. M. (2007) · Blood · doi:10.1182/blood-2007-06-094680 · Cited by 86
Radiolabelled RGD peptides and peptidomimetics for tumour targeting
Haubner, R., & Decristoforo, C. (2009) · Frontiers in bioscience · doi:10.2741/3283 · Cited by 86
β3-Integrin Regulates Vascular Endothelial Growth Factor-A–Dependent Permeability
Robinson, S. D., Reynolds, L. E., Wyder, L., Hicklin, D. J., & Hodivala‐Dilke, K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143857.27408.de · Cited by 85
Integrin affinity modulation in angiogenesis
Mahabeleshwar, G. H., Chen, J., Feng, W., Somanath, P. R., Razorenova, O. V., & Byzova, T. V. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5234 · Cited by 81
Application of RGD-containing peptides as imaging probes for alphavbeta3 expression
Dijkgraaf, I. (2009) · Frontiers in bioscience · doi:10.2741/3284 · Cited by 81
Weng, S., Zemany, L., Standley, K. N., Novack, D. V., Regina, M. L., Bernal‐Mizrachi, C., Coleman, T., & Semenkovich, C. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1137612100 · Cited by 80
Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide.
Nicosia, R. F., & Bonanno, E. (1991) · PubMed Central · Cited by 78
Dissection of platelet and myeloid cell defects by conditional targeting of the β3‐integrin subunit
Morgan, E. A., Schneider, J. G., Baroni, T. E., Uluçkan, Ö., Heller, E., Hurchla, M. A., Deng, H., Floyd, D. H., Berdy, A., Prior, J. L., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-138420 · Cited by 70
Cooperation between VEGF and β3 integrin during cardiac vascular development
Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., & Cheresh, D. A. (2006) · Blood · doi:10.1182/blood-2005-10-038893 · Cited by 68
Self-citationGruber, G., Hess, J., Stiefel, C., Aebersold, D. M., Zimmer, Y., Greiner, R. H., Studer, U. E., Altermatt, H. J., Hlushchuk, R., & Djonov, V. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602278 · Cited by 66
Besides adhesion: new perspectives of integrin functions in angiogenesis
Serini, G., Napione, L., Arese, M., & Bussolino, F. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn045 · Cited by 61
Integrin signaling and lung cancer
Caccavari, F., Valdembri, D., Sandri, C., Bussolino, F., & Serini, G. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10976 · Cited by 60
Neutrophils sense flow-generated stress and direct their migration through αVβ3-integrin
Rainger, G. E., Buckley, C. D., Simmons, D. L., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.3.h858 · Cited by 59
Bauer, K., Mierke, C. T., & Behrens, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22879 · Cited by 58
Lu, X., Lu, D., Scully, M. F., & Kakkar, V. V. (2008) · Perspectives in Medicinal Chemistry · doi:10.1177/1177391x0800200003 · Cited by 54
Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells
Pan, H., Wanami, L. S., Dissanayake, T. R., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0179-y · Cited by 50
The angiogenic response is dictated by β3 integrin on bone marrow–derived cells
Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802179 · Cited by 48
Role of integrin αvβ3 in the early phase of liver metastasis: PET and IVM analyses
Kikkawa, H., Kaihou, M., Horaguchi, N., Uchida, T., Imafuku, H., Takiguchi, A., Yamazaki, Y., Koike, C., Kuruto, R., Kakiuchi, T., et al. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1021356019563 · Cited by 45
Baum, O., Hlushchuk, R., Forster, A., Greiner, R. H., Clézardin, P., Zhao, Y., Djonov, V., & Gruber, G. (2007) · PubMed · Cited by 42
Martin, P. L., Jiao, Q., Cornacoff, J. B., Hall, W. C., Saville, B. A., Nemeth, J. A., Schantz, A., Mata, M., Jang, H., Fasanmade, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2623 · Cited by 42
Integrin-mediated regulation of neurovascular development, physiology and disease
McCarty, J. H. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7767 · Cited by 37
Kanamori, M., Kawaguchi, T., Berger, M. S., & Pieper, R. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605344200 · Cited by 36
Specific Targeting of Human Integrin αvβ3 with 111In-Labeled Abegrin™ in Nude Mouse Models
Liu, Z., Jia, B., Zhao, H., Chen, X. S., & Wang, F. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0302-4 · Cited by 30
Cited by
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Harjunpää, H., Llort Asens, M., Guenther, C., & Fagerholm, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01078 · Cited by 764
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“a binding motif for integrins, such as αvβ3, which is specifically expressed on tumor endothelia [104], and those that have a form of aminopeptidase N (CD13) that binds peptides with the NGR motif.”
BackgroundThe Intersection between Tumor Angiogenesis and Immune Suppression
Rahma, O. E., & Hodi, F. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1543 · Cited by 472
Tumor penetrating peptides for improved drug delivery
Ruoslahti, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 459
Metadata
- Authors
- Weis, S. M., & Cheresh, D. A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-09-01
- Volume
- 1
- Issue
- 1
- Pages
- a006478-a006478
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2127905380
- Cited by
- 311
- References
- 121
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.